Clinical Trials Browser

Phase 2 × salicylhydroxamic acid × Lymphoid × Clear all

NCT04850664 2021-08-06

CBOT-OUD

Phase 2 Unknown

Lymphoma, Follicular, Opioid-Related Disorders, Substance Withdrawal Syndrome